openPR Logo
Press release

Allergy Diagnostics Market Set to Grow at 10.5% CAGR to 2022 in North America and Europe Driven by Key Top Players Like Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi Chemical Co., Ltd., INDOOR Biotechnologies and Allergy Therapeutics

01-23-2019 02:39 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ReportsnReports

The allergy diagnostics market

The allergy diagnostics market

#Download Free Brochure Now at Allergy Diagnostics Market Report Now Available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=320079 .

Key Target Audience of Allergy Diagnostics Market Report covered are Allergy diagnostics reagents, kits, and instruments manufacturers, Allergy diagnostics vendors and distributors, Hospitals, Diagnostic laboratories, Allergy diagnostic service providers, Academic research institutes, Venture capitalists and investors, Research institutes and clinical research organizations (CROs) and Government associations.

Allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The assay kits segment is expected to lead the global allergy diagnostics market in 2017.

The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region. By product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.

#Table of Content
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Allergy Diagnostics Market, By Product & Service
7 Allergy Diagnostics Market, By Test
8 Allergy Diagnostics Market, By Allergen
9 Allergy Diagnostics Market, By End User
10 Allergy Diagnostics Market, By Region
11 Competitive Landscape

Allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, inhaled allergens segment is expected to account for the largest share of the allergy diagnostics market. Increasing environmental pollution is one of the major factors driving the growth of this segment. Assay kits segment is expected to lead the global allergy diagnostics market in 2017.

#Get Discount on Allergy Diagnostics Market Now at
http://www.reportsnreports.com/contacts/discount.aspx?name=320079 .

In addition, allergy diagnostics market company profiles comprise product portfolios, developments, and strategies adopted by market players to maintain & increase their shares in market. Report analyses allergy diagnostics market by product and service, test, allergen, end user, & region.

Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities. The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region.

Premium Insights
1 Allergy Diagnostics: Market Overview
2 Allergy Diagnostics Market, By Allergens (2017)
3 Geographic Snapshot of the Allergy Diagnostics Market
4 Allergy Diagnostics Market, By Test Type, 2017 vs 2022

#Click Here for More Details on Allergy Diagnostics Market Report Now at
https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=320079 .

The key players in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US),Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Allergy Therapeutics (UK), HAL Allergy Group (Netherlands), Theradiag (France), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), and Demeditec Diagnostics GmbH (Germany).

Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergy Diagnostics Market Set to Grow at 10.5% CAGR to 2022 in North America and Europe Driven by Key Top Players Like Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi Chemical Co., Ltd., INDOOR Biotechnologies and Allergy Therapeutics here

News-ID: 1526355 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Allergy

Allergy Shots Market | ALK Abello, Aimmune Therapeutics, Allergy Therapeutics, A …
The global allergy shots market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the allergy shots market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the
Allergy Shots Market: Rising Demand and Advancements in Allergy Treatment
Market Overview: The Allergy Shots market refers to the production, distribution, and utilization of immunotherapy treatments known as allergy shots or allergen immunotherapy. Allergy shots are a form of treatment for allergies, particularly for allergic rhinitis (hay fever), allergic asthma, and insect sting allergies. They involve the administration of gradually increasing doses of allergens, such as pollen, dust mites, pet dander, or insect venom, to desensitize the immune system and
Allergy Treatment Market Increasing Demand By Allergy Type: Eye Allergy, Rhiniti …
Acumen Research and Consulting has announced the addition of the "Allergy Treatment Market” report to their offering. The Allergy Treatment Market Report 2018 is an in depth study analyzing the current state of the Allergy Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Allergy Treatment Market provides analysis of China market covering the industry trends, recent
Allergy Immunotherapy Market to Witness Huge Growth by Key Players: Allergy Ther …
According to a recent research study "Allergy Immunotherapy Market, by immunotherapy Type (SCIT, SLIT), By Type of Allergy (Asthma, Food Allergy, Allergic Rhinitis and Others) opportunities and forecast 2020-2026" published by Data Library Research, the Allergy Immunotherapy Market Studies many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key
Allergy Treatment Market Report 2018: Segmentation by Allergy Type (Food Allergy …
Global Allergy Treatment market research report provides company profile for Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, Teva Pharmaceutical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Allergy Treatment Global Market 2018: Key Players – ALK, Stallergenes Greer, A …
Allergy Treatment Industry Description Wiseguyreports.Com Adds “Allergy Treatment -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database This report studies the global Allergy Treatment market, analyzes and researches the Allergy Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like  ALK  Stallergenes Greer  Allergy Therapeutics  HAL Allergy Group  Circassia  GlaxoSmithKline plc  Sunovion Pharmaceuticals  Teva Pharmaceutical Industries  Allergan plc  Allergon